Genestra Brands OSG Bio
Natural health product licensed in Canada
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80026994
- Status
- Inactive licence
- Licence date
- 19 August 2011
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 2,000 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (4 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Manganèse: up to 9 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSAEuropean Food Safety Authority. for adults (8 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vanadium Source : Sulfate de vanadyle | 3.75 mcg | Not calculated |
| Calcium Source : Ascorbate de calcium | 31.25 mg | 125,000 µg |
| Vitamine C Source : Ascorbate de magnésium | 500 mg | 2,000,000 µg |
| Vitamine C Source : Ascorbate de calcium | 500 mg | 2,000,000 µg |
| Vitamine C Source : Ascorbate de manganèse | 500 mg | 2,000,000 µg |
| Manganèse Source : Ascorbate de manganèse | 2.25 mg | 9,000 µg |
| Vitamine K1 Source : Phylloquinone | 25 mcg | 100 µg |
| Vitamine D Source : Cholécalciférol Potency : 250 UI | 6.25 mcg | 25 µg |
Non-medicinal ingredients
Silice, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
An antioxidant and a factor in the maintenance of good health. Helps the body to metabolize carbohydrates, fats and proteins and helps in the absorption and use of calcium and phosphorus; helps in development and maintenance of night vision, bones, cartilage, teeth and gums; helps to maintain eyesight, skin, membranes, immune and proper muscle function; helps in wound healing and helps in tissue and connective tissue formation; helps to prevent vitamin C, vitamin D and manganese deficiencies. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80026994
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.